Press release
EpiCast Report: Fragile X Syndrome - Epidemiology Forecast to 2026
Fragile X syndrome (FXS) is the most frequent form of inherited intellectual disability. FXS affects both men and women and the condition is also linked to other neurological and psychiatric disorders (CDC, 2017a). FXS is caused by an abnormal expansion in the number of the trinucleotide CGG repeats located in the 5' UTR in the fragile X mental retardation 1 gene (FMR1) at Xq27.3. Patients affected with FXS have more than 200 repeats of the CGG trinucleotide caused by full mutation of the FMR1 gene (NFXF, 2017; Saldarriaga et al., 2014).
Request For Sample Report @ https://www.marketresearchreports.biz/sample/sample/1581003
In the 7MM, the diagnosed prevalent cases of FXS are expected to increase from 88,457 cases in 2016 to 91,919 cases in 2026, at an Annual Growth Rate (AGR) of 0.39% per year. In the five major European markets (5EU: France, Germany, Italy, Spain, and the UK), the diagnosed prevalent cases of FXS will increase from 36,942 cases in 2016 to 37,767 cases in 2026, at an AGR of 0.22%. When examining the AGR by individual market, GlobalData forecasts that all markets will see an increase in the diagnosed prevalent cases of FXS during the forecast period except Germany and Japan, with AGRs of negative 0.22% and negative 0.31%, respectively, during the forecast period.
Complete Report Details @ https://www.marketresearchreports.biz/reports/1581003/epicast-report-fragile-x-syndrome-epidemiology-forecast-to-2026-market-research-reports
GlobalData epidemiologists developed the epidemiological forecast for the diagnosed prevalent cases of FXS segmented by age and sex in the 7MM. GlobalData epidemiologists used consistent methodology across the 7MM to ensure the comparability of the disease populations across the 7MM.
Scope
- The Fragile X Syndrome (FXS) EpiCast Report provides an overview of the risk factors and global trends of FXS in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
- This report also includes a 10-year epidemiological forecast of the diagnosed prevalent cases of FXS in these markets from 2016-2026. The prevalent cases are further segmented by age (0-19 years, 20-39 years, 40-59 years, 60-79 years, and 80 years and older) and sex.
- The FXS epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
Request For TOC Report @https://www.marketresearchreports.biz/reports/1581003/epicast-report-fragile-x-syndrome-epidemiology-forecast-to-2026-market-research-reports/toc
Reasons to buy
The FXS EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global FXS market.
- Quantify patient populations in the global FXS market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for FXS therapeutics in each of the markets covered.
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact Us
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release EpiCast Report: Fragile X Syndrome - Epidemiology Forecast to 2026 here
News-ID: 955294 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for FXS
United States Fragile X Syndrome (FXS) Industry Intelligence Forecast Report 202 …
DataM Intelligence has released an in-depth research report on "Fragile X Syndrome Treatment Market Size 2025". This report delivers power-packed insights into key growth drivers, market segmentation, regional trends, CAGR forecasts, revenue performance of top players, and emerging opportunities. Gain a 360° market perspective with detailed analysis on value, volume, and future development trends your ultimate guide to spotting high-impact opportunities and staying ahead in this dynamic market.
Download Your Sample…
Fragile X Syndrome (FXS) Market is expected to reach USD 2.5 billion by 2034
Fragile X Syndrome (FXS) is the most common inherited cause of intellectual disability and a leading genetic contributor to autism spectrum disorders. Caused by a mutation in the FMR1 gene, FXS affects both males and females, though symptoms are typically more severe in males. With no FDA-approved treatment available, management has largely focused on behavioral therapies and symptom-based pharmacological interventions.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71653
However, recent…
Fragile X Syndrome (FXS) Treatment Market Size Projected To Reach 2.81 Billion B …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Is the Projected Growth of the Fragile X Syndrome (FXS) Treatment Market?
Over the past few years, the market size for fragile X syndrome FXS treatments has seen robust growth. The anticipated rise is from a value of $1.92 billion in 2024 to $2.08 billion in 2025, recording a compound annual growth rate…
Fragile X Syndrome Fxs Treatment Market Size, Share & Trends [2035]
The Fragile X Syndrome Market Is Set To Grow At An Estimated CAGR Of 8.4% From 2025 To 2034, Rising From $1.2 Billion In 2024 To $2.6 Billion By 2034.
On April 15, 2025, Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Fragile X Syndrome Fxs Treatment market goods. The market study excludes key regions that are…
Fragile X Syndrome (Fxs) Treatment Industry is Expected to Reach $$$ Billion by …
DataM Intelligence has published a new research report on "Fragile X Syndrome (Fxs) Treatment Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample…
Fragile X Syndrome (FXS) Treatment Market Insights: Growth, Trends, and Key Play …
"Fragile X Syndrome Market Accounted For US$ 55.89 Billion In 2020 And Is Estimated To Be US$ 335.15 Billion By 2030 And Is Anticipated To Register A Cagr Of 19.8%.".
With thorough company profiles, recent developments, and other information, the Fragile X Syndrome (FXS) Treatment Market Report provides an in-depth analysis of major trends, motivating reasons, obstacles, segmentation, regulatory policies, and important players. The Fragile X Syndrome (FXS) Treatment Market Report…
